SCHEMBL6830633

SCHEMBL6830633

Cc1sc(C(=O)Nc2ccc(C#N)cc2C(=O)O)cc1S(=O)(=O)N1CCN(c2ccccn2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
USP2 O75604 2/20 0.48
TSHR P16473 2/20 0.48
GAA P10253 1/20 0.48
ALB P02768 1/20 0.46
KDM4E B2RXH2 3/20 0.45
PKM P14618 1/20 0.45
GPR6 P46095 1/20 0.43
PDK1 Q15118 1/20 0.42
PDK2 Q15119 1/20 0.42
PDK3 Q15120 1/20 0.42
PDK4 Q16654 1/20 0.42
MAPT P10636 4/20 0.42
LMNA P02545 2/20 0.42
MAPK1 P28482 2/20 0.42
ALDH1A1 P00352 3/20 0.41
HPGD P15428 2/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6818233 0.91 ALB (0.47) MEN1KMT2ASMN1; SMN2USP2TSHR
SCHEMBL6818779 0.89 ALB (0.51) MEN1KMT2ASMN1; SMN2TSHRALB
SCHEMBL6932502 0.85 ALB (0.54) MEN1KMT2ASMN1; SMN2TSHRALB
SCHEMBL6930797 0.84 ALB (0.53) MEN1KMT2ASMN1; SMN2TSHRALB
SCHEMBL6834002 0.83 MAPT (0.52) MEN1KMT2ASMN1; SMN2USP2TSHR
SCHEMBL6833979 0.83 HTT (0.52) MEN1KMT2ASMN1; SMN2USP2TSHR
SCHEMBL6835846 0.83 ALB (0.66) MEN1KMT2ASMN1; SMN2GAAALB
SCHEMBL6819583 0.83 ALB (0.53) MEN1KMT2ASMN1; SMN2TSHRGAA
SCHEMBL6817870 0.82 ALB (0.51) MEN1KMT2ASMN1; SMN2USP2TSHR
SCHEMBL6814358 0.82 ALB (0.51) MEN1KMT2ASMN1; SMN2TSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed
WO-2004018428-A1 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 MEN1 4132/4885KMT2A 2853/4885SMN1; SMN2 2022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.